The Food and Drug Administration (FDA) is asking public stakeholders, such as patient groups, healthcare professionals, and academics, to express their interest in joining regular consultation meetings about the reauthorization of the Medical Device User Fee Amendments (MDUFA). The FDA's authority to collect user fees for reviewing medical devices will expire in September 2022 unless new legislation is enacted. These meetings aim to gather input from various stakeholders to help shape the new MDUFA program and ensure ongoing discussions with patient and consumer groups. Interested parties should notify the FDA of their intent to participate by February 26, 2021.
Simple Explanation
The FDA wants people like doctors and patients to tell them if they want to join important talks about fees for checking medical devices. They need to know who wants to join by February 26, 2021, so they can keep getting money to do this work after September 2022.